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Abstract
 
Polyamine synthesis from 
 
l
 
-ornithine is essential for 
 
Leishmania 
 
growth. We have investigated the
dependence of 
 
Leishmania
 
 infection on arginase, which generates 
 
l
 
-ornithine, in macrophages
from BALB/c, C57BL/6, and nitric oxide synthase II (NOS II)-deficient mouse strains. We have
found that 
 
N
 
v
 
-hydroxy-
 
l
 
-arginine (LOHA), a physiological inhibitor of arginase, controls cellu-
lar infection and also specifically inhibits arginase activity from 
 
Leishmania major 
 
and
 
 Leishmania in-
fantum
 
 parasites. The effect was proportional to the course of infection, concentration dependent
up to 100 
 
m
 
M, and achieved without an increase in nitrite levels of culture supernatants. More-
over, when the 
 
l
 
-arginine metabolism of macrophages is diverted towards ornithine generation
by interleukin 4–induced arginase I, parasite growth is promoted. This effect can be reversed by
 
LOHA. Inhibition of NOS II by 
 
N
 
G
 
-methyl-
 
l
 
-arginine (LNMMA) restores the killing obtained
in the presence of interferon (IFN)-
 
g
 
 plus lipolysaccharide (LPS), whereas the nitric oxide scav-
enger 2-(4-carboxyphenyl)-4,4,5,5,-tetramethylimidazoline-3-oxide-1-oxyl (carboxy-PTIO)
was without effect. However, exogenous 
 
l
 
-ornithine almost completely inhibits parasite killing
when added in the presence of LOHA to macrophages from NOS II–deficient mice or to
BALB/c-infected cells activated with IFN-
 
g
 
 plus LPS. These results suggest that LOHA is an ef-
 
fector molecule involved in the control of 
 
Leishmania
 
 infection. In addition, macrophage arginase I
induction by T helper cell type 2 cytokines could be a mechanism used by parasites to spread in-
side the host.
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Introduction
 
Leishmania 
 
infection
 
 
 
is one the best elucidated models for
studying defense mechanisms in murine macrophages. Re-
sistance or susceptibility to the infection in vivo is regulated
by the Th1 or Th2 type of immune response (1). The inhi-
bition of IL-12 synthesis and the induction of IL-10 and
TGF-
 
b
 
 by infected cells rank among the most important
strategies used by the parasite to escape the immune control
(2). However, macrophages under appropriate conditions
can control infection of 
 
Leishmania
 
, and this effector mech-
anism is triggered when cells are activated by cytokines re-
leased mainly by Th1-type CD4
 
1
 
 cells. These include
IFN-
 
g
 
 and TNF-
 
a
 
 as inducers of nitric oxide synthase II
(NOS II), the main pathway responsible for the killing of
 
Leishmania
 
. In the mouse model, parasite killing is generally
accepted to occur by the toxic capacities of nitric oxide
(NO), one of the products of this enzyme (3).
Activated murine macrophages and dendritic cells me-
tabolize arginine by two alternative pathways involving ei-
ther the enzymes NOS II or arginase (4). NOS II catalyzes
 
the conversion of 
 
l
 
-arginine into NO and citrulline in
two steps. In the first one, arginine is hydroxylated to 
 
N
 
v
 
-
hydroxy-
 
l
 
-arginine (LOHA) and, in the second one,
LOHA is further oxidized to citrulline and NO (5). Argi-
nase hydrolyzes arginine to ornithine and urea. In previous
studies we demonstrated that the balance between the two
enzymes is competitively regulated by Th1 and Th2 cells
via their secreted cytokines: Th1 cells induce NOS II,
whereas Th2 cells induce arginase I, one of the two en-
zyme isoforms. Moreover, induction of any of these en-
zymes is accompanied by suppression of the other, indica-
tive of two competitive states in murine macrophages (6, 7).
This competition also occurs at other levels; arginase re-
duces the synthesis of NO by substrate depletion (7, 8), and
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Inhibition of 
 
Leishmania
 
 Infection by 
 
N
 
v
 
-Hydroxy-
 
l
 
-Arginine
 
LOHA is the most effective physiological inhibitor of argi-
nases (9). However, this oxidized amino acid is not merely
an unstable intermediate in the synthesis of NO. Several
studies have demonstrated that it can be secreted by cells
and is present in human and rat plasma (10). Also, it has
been reported that LOHA is a target of several inorganic
radicals, such as superoxide (11), as well as substrate of
other oxidases apart from NOS II (12), yielding alternative
nitrogen derivatives. Thus, only the conversion of arginine
to LOHA remains an exclusive feature of NOSs.
In contrast to the well-documented role of NOS II in
macrophages, only few data exist about the functions of ar-
ginase I. Nevertheless, one of the metabolic fates of 
 
l
 
-orni-
thine is polyamine synthesis. In this pathway, arginine re-
sults in ornithine through the action of arginase and is
further converted to putrescine by ornithine decarboxylase
(ODC).
Polyamines are essential for the growth of all trypanoso-
matidae. Therefore, the inhibition of polyamine synthesis is
an established therapeutic approach for the treatment of
parasitic diseases (13) as well as cellular growth disorders
(14).
The only reported study on the regulation of arginase in-
duction in vivo
 
 
 
in a parasitic disease demonstrates that the
killing of 
 
Trypanosoma brucei 
 
by NOS II induction is re-
stored by the early induction of arginase, which competes
with NOS II for substrate availability (8).
In this work we have investigated the possible roles of
LOHA in the interaction between macrophages and 
 
Leish-
mania,
 
 as (a) some parasite
 
 
 
strains have arginase activity
(15), (b) LOHA is a potent inhibitor of arginases, and (c)
the killing capacities of NO in infected cells have usually
been demonstrated by adding NOS inhibitors that abol-
ished both NO and LOHA generation (16).
The results obtained point to a novel defense mechanism
against 
 
Leishmania
 
 infection, mediated by LOHA, through
the inhibition of arginase from parasites. Moreover, in
agreement with this finding, our data also suggest that argi-
nase I induction in macrophages is used by the parasite to
spread inside the host.
 
Materials and Methods
 
Medium and Reagents.
 
Macrophage cultures were performed
in RPMI 1640 supplemented with 10% heat-inactivated FCS, 2
mM 
 
l
 
-glutamine, 60 mM 2-mercaptoethanol, 100 U/ml penicil-
lin, and 100 
 
m
 
g/ml streptomycin (GIBCO BRL). Recombinant
murine IL-4 and IFN-
 
g 
 
were obtained from PeproTech; LPS
from 
 
Salmonella minnesota 
 
and 
 
l
 
-ornithine from Sigma-Aldrich;
endotoxin-free superoxide dismutase (SOD) from Roche Molec-
ular Biochemicals; 2-(4-carboxyphenyl)-4,4,5,5,-tetramethylim-
idazoline-3-oxide-1-oxyl (carboxy-PTIO) from ICN Biomedi-
cals; and 
 
N
 
G
 
-methyl-
 
l
 
-arginine (LNMMA) and LOHA from
Alexis Corp.
 
Animals, Parasites, and Generation of Bone Marrow–derived Mac-
rophages.
 
Mice of strains BALB/c and C57BL/6, 6–8 wk of age,
were purchased by Janvier España, Sociedad Limitada (Spain) and
tested routinely in the Parasitology Unit for murine pathogens.
C57BL/6 NOS II knockout mice were from the specific patho-
gen-free animal facilities of the Max-Planck-Institut and were
used between 6–8 wk of age.
 
Leishmania infantum 
 
WHO reference strain (M/CAN/ES/88/
CHUMI) and 
 
Leishmania major 
 
WHO reference strain (M/IR/
 
2
 
/173) promastigotes were isolated and propagated as published
elsewhere (17). Macrophages were derived from bone marrow
cells as described previously (6).
 
Infection of Bone Marrow–derived Macrophages with Leishmania
Species and Activation with Cytokines.
 
Stationary-phase promas-
tigotes were added to bone marrow–derived macrophages
(BMM
 
f
 
) cultures (10
 
6
 
 cells/ml) in 24-well plates (COSTAR)
with round cover slides, at parasite to cell ratio of 3:1. The plates
remained at 26
 
8
 
C for 2 h. Nonphagocytosed parasites were re-
moved by washing the cells, and then cultures were treated with
20 ng/ml IL-4, 5 ng/ml IFN-
 
g
 
 plus 0.1 
 
m
 
g/ml LPS with or
without 100 
 
m
 
M LOHA (unless indicated), 250 
 
m
 
M 
 
l
 
-ornithine,
and 100 
 
m
 
M carboxy-PTIO or 5 mM LNMMA and transferred
to a CO
 
2 
 
incubator at 37
 
8
 
C for an infection period of 48 h, ex-
cept for the kinetic experiments. Finally, the round cover slides
were removed from the plates, mounted, and dyed with Giemsa
staining (DiffQuick; QCA). The percentage of infected cells as
well as the number of amastigotes in 100 cells were counted by
microscopic examination of stained preparations.
 
Measurement of Arginase Activity and Nitrite Concentration in In-
fected BMM
 
f
 
.
 
Arginase activity was measured in macrophage
lysates and in promastigote lysates, as described previously (6).
Nitrites were measured in the supernatant from all infected cul-
tures both in the presence and the absence of carboxy-PTIO,
LOHA, or LNMMA by the Griess reagent, using NaNO
 
2
 
 as
standard curve.
 
Cellular Viability.
 
Experiments testing macrophage viability
in the presence of LOHA were made by using the 3-[-4,5-di-
Figure 1. LOHA inhibits parasite growth in two Leishmania species.
BMMf from BALB/c mice were infected with either L. infantum (open
symbols) or L. major (filled symbols) promastigotes, in the presence of in-
creasing amounts of LOHA for 48 h (A) or with 100 mM LOHA vs. time
(B). Cells were used to determine both the number of intracellular para-
sites (circles) and the percentage of infection (numbers), whereas nitrite
concentrations (squares) were measured in culture supernatants from
those cells, as described in Materials and Methods. 
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methyltiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) re-
duction assay, as described previously (18).
 
Data Presentation.
 
Data reported are means 
 
6
 
 SD (
 
n
 
 
 
5
 
 4)
from at least three independent experiments. Student’s paired 
 
t
 
test was used to analyze statistical significance (
 
P 
 
,
 
 0.05).
 
Results and Discussion
 
In this work we have analyzed the response of 
 
Leishma-
nia
 
-infected macrophages, under conditions in which cells
are induced to have either a functional NOS II or a func-
tional arginase I.
There are few consistent data reporting arginase activity
in 
 
Leishmania 
 
species (15).
 
 
 
Thus, we started measuring argi-
 
nase activity in promastigote lysates of 
 
L. major
 
 and 
 
L. infan-
tum
 
. The specific enzyme activities, measured at 1 mM
 
l
 
-arginine (the concentration found in RPMI), were
11.34 
 
6 
 
1.80 mU/10
 
7
 
 parasites and 9.8 
 
6
 
 0.5 mU/10
 
7
 
parasites, respectively. To confirm that the urea measured in
the assay was derived from arginase and not from other
urea-producing enzymes, we determined both activities in
the presence of LOHA, the most specific arginase inhibitor
commercially available (Ki 
 
z
 
30 
 
m
 
M; reference 19). We
found that 100 
 
m
 
M LOHA decreased enzyme activity to
0.3 mU/10
 
7
 
 parasites for 
 
L. major 
 
and 0.15 mU/10
 
7
 
 para-
sites for L. infantum. This amounts to z98% inhibition. In
conclusion, these data demonstrate that both species contain
a functional arginase that is efficiently inhibited by LOHA.
Analysis of LOHA-dependent Inhibition of Parasite Infec-
tion. To further assess the effect of LOHA on intracellular
parasites, we infected BMMf with L. major and L. infantum
promastigotes in the presence of increasing LOHA concen-
trations (Fig. 1 A) and determined the kinetics of the infec-
tion up to 48 h (Fig. 1 B). The inhibition leads to a dra-
matic decrease in both the number of intracellular
amastigotes and the percentage of cells infected. The viabil-
ity of macrophages was not compromised, as assessed by
the MTT reduction assay (control: 0.75 6 0.02 versus
LOHA: 0.78 6 0.03). Additionally, the number of remain-
ing amastigotes was reduced by the inhibitor during the
time course of infection, suggesting a cytotoxic effect of
LOHA on parasites.
Figure 2. Micrographs from L. infantum–infected BALB/c macrophages
in the absence (A) or presence (B) of 100 mM LOHA for 48 h. Original
magnification: 3450.
Figure 3. The susceptibility or resistance to Leishmania infection re-
flects intrinsic differences on BMMf-induced arginase I and NOS II.
BALB/c (white bars) or C57BL/6 cells (black bars) were infected with L.
infantum promastigotes and treated with IL-4 or IFN-g plus LPS with or
without LOHA or LNMMA. After 48 h, infected cells were used to de-
termine intracellular parasites and cellular infection (numbers; A) or to
measure arginase/nitrite values (B). **P , 0.05 by Student’s paired t test.780 Inhibition of Leishmania Infection by Nv-Hydroxy-l-Arginine
To check that LOHA was also effective in inhibiting argi-
nase activity in our cultures, we have measured the levels of
enzyme activity in infected macrophages, during the course
of cellular infection. The data reveal changes in enzyme ac-
tivity from 25.67 6 1.24 in controls to 1.23 6 0.08 in the
presence of 100 mM LOHA. This suggests that the inhibi-
tion of parasite growth may be related to arginase inhibition.
LOHA induces apoptosis in tumor cell lines which are
dependent on polyamine synthesis for proliferation (20,
21). Thus, the same is likely to occur in infected cultures,
where the growth of parasites is prevented by inhibition of
l-ornithine supply. Macrophages, a differentiated, stable
population, are not dependent on polyamines for growth
and therefore remain viable.
The inhibition of cellular infection can be further appre-
ciated in the micrographs (Fig. 2) in which parasitization
(Fig. 2 A) is impaired by LOHA addition (Fig. 2 B).
LOHA is a stable intermediate in the NOS reaction and
can be further metabolized to other reactive nitrogen inter-
mediates (RNIs), including NO by cellular oxidases (12).
To be certain that the cytotoxic effect of LOHA was not
due to NO production, we measured nitrite concentrations
in culture supernatants (Fig. 1 A). LOHA did not increase
nitrite levels along the dose–response curve, suggesting that
NO is not involved in the antiparasitic effects of LOHA.
Macrophage Arginase I and NOS II Regulate Parasitic
Growth in Opposing Ways. It is well established that there
are strain-related differences with respect to resistance ver-
sus susceptibility to Leishmania infection: BALB/c mice de-
velop a Th2-dominant response and become susceptible,
whereas C57BL/6 mice control infection due to a predom-
inant Th1-type response (1). Here we have compared the
ability of macrophages from the two strains to control in-
fection, depending on the fate of l-arginine metabolism.
Therefore, infected cells were treated with IL-4 for arginase
I induction or with IFN-g plus LPS to have an optimal
NOS II induction. As shown in Fig. 3, BMMf from
BALB/c mice reach a higher level of infection and intracel-
lular parasites than those from C57BL/6. In the presence of
IL-4, when only arginase I is induced, both strains respond
with a huge increment in parasite proliferation. However,
the difference in arginase-specific activity between them is
parallel to a difference in the number of total amastigotes
that replicate. The opposite is the case when l-arginine is
metabolized via NOS II; C57BL/6 BMMf have higher
levels of nitrite than BALB/c cells (Fig. 3 B). Accordingly,
the killing was more prominent in resistant cells compared
with susceptible cells. This effect was reverted by the NOS
inhibitor LNMMA (Fig. 3 A), as reported previously (16).
However, in the presence of LOHA, the intracellular para-
sitation was almost prevented in all treated cells, including
those activated with IFN-g plus LPS, in which it was diffi-
cult to find intracellular amastigotes.
Similar results have been recently reported in macro-
phages from prototypical Th1 and Th2 mouse strains, which
differed in their ability to divert l-arginine metabolism;
macrophages from BALB/c mice mainly produced l-orni-
thine whereas those from C57BL/6 generated NO when
induced with LPS (22). These data have supported our pre-
vious observation that l-arginine metabolism towards argi-
nase I or NOS II determines in the macrophage different
functional stages (7). Here we present evidence confirming
that the final fate of l-arginine regulate the growth of Leish-
mania inside macrophages.
The NO Scavenger Carboxy-PTIO Did Not Modify Infection
in the Presence of NOS II Induction. In previous experi-
ments we added LOHA to cultured infected cells. This
modified amino acid is both a substrate for NOS II (Km 5
6 mM) and a product of the enzyme (23). Thus, we propose
that endogenous LOHA production via NOS II could, at
Figure 4. Scavenging of NO by carboxy-PTIO does
not modify cellular infection. Macrophages from
BALB/c (A) and C57BL/6 mice (B) were infected
with  L. infantum promastigotes and treated with LOHA
or carboxy-PTIO with or without LNMMA, in the
absence (control) or presence of IFN-g plus LPS for
48 h. Results represent the number of intracellular par-
asites in 100 cells (bars) and the percentage of infected
cells (numbers).
Table I. Nitrite Concentrations in Culture Supernatants of Activated-Infected BMMf in the Presence of LOHA and Carboxy-PTIO
Nitrites (mM)
Treatment None LOHA PTIO NMMA NMMA 1 PTIO
Control 1.79 6 0.21 1.74 6 0.23 1.81 6 0.19 1.73 6 0.25 1.78 6 0.20
IFN-g 1 LPS 33.56 6 2.92 33.58 6 2.22 65.13 6 3.01 3.75 6 0.29 12.03 6 1.78781 Iniesta et al. Brief Definitive Report
least in part, be responsible for the killing of Leishmania in
IFN-g plus LPS–activated cells. To look at the effects of
LOHA in the absence of NO, we added the NO scavenger
carboxy-PTIO. This molecule oxidizes NO? to NO2
2 in a
molar to molar ratio and is being used to increase the sensi-
bility of the Griess reaction, as it generates higher levels of
nitrites in culture supernatants (24). The results presented in
Fig. 4 were surprising, as 100 mM of the scavenger did not
revert the killing obtained by NOS II induction. The lack
of effect was the same in cells from the two strains of mice,
but was reverted in the presence of LMMNA plus the scav-
enger. However, in the same experiment, exogenous
LOHA further decreased the number of intracellular para-
sites when added together with IFN-g plus LPS.
Supernatant from all infected cultures were collected for
nitrite determination and results presented in Table I. Al-
though nitrite levels are not modified by exogenous
LOHA, even in the presence of NOS II induction, car-
boxy-PTIO almost duplicates nitrite concentrations as ex-
pected. This effect was proven to be proportional to the
scavenger concentration (data not shown), as described
previously (24). These results suggest that LOHA is not be-
ing metabolized by NOS II, at least to enhance nitrite se-
cretion.
It has been reported that NOS II induction in macro-
phages generates 20% of the total reaction products as LOHA
(25). This could account for z10 to 30 mM of this amino
acid secreted into the culture media. However, it is impor-
tant to note that we have not measured the real amounts of
LOHA produced by activated cells. Thus, we do not know
what concentration affects intracellular parasites.
In conclusion, our data suggest that the induction of
NOS II in activated cells may have a double killing effect:
on the one hand, the putative production of endogenous
LOHA and the consequent inhibition of arginase from par-
asites; on the other hand, the production of RNIs that have
proved to be cytotoxic against Leishmania. The fact that
parasite killing could not be reverted by sequestering of
NO does not invalidate the role of other RNIs not scav-
enged by carboxy-PTIO (24). Moreover, we think that
NO has an undoubted role in modulating the early re-
sponse to infection, inducing T cells to switch towards pro-
tective responses (3).
Effect of SOD on the Inhibition of Parasite Infection by
LOHA. LOHA, when added to murine macrophages,
can be the target of superoxide and yield NO as one of the
reaction products (11). However, the respiratory burst, and
thus, the O2
2 generation by Leishmania-infected cells, ap-
pears to be inefficient. The parasite has its own SOD to
evade host attack (1). Moreover, previous reports have
demonstrated that the killing of the parasite by NO is inde-
pendent of superoxide or peroxynitrite formation (16).
Nevertheless, to rule out the possible involvement of these
radicals on the observed antiparasitic activity of LOHA, we
added SOD. As can be seen in Fig. 5, SOD does not mod-
ify parasite killing in the presence of the inhibitor. Thus,
these data suggest that the effector mechanisms of LOHA
occur independently of superoxide generation.
It has been recently demonstrated that the in vivo re-
sponse to Leishmania infection depends on a functional NOS
II, but could be controlled in the absence of respiratory burst
(26). Our data are in agreement with this, in the sense that
NOS II induction is essential to restrain Leishmania infection,
but point to LOHA as a new molecule, along with the
RNI, directly involved in the effects of NOS II induction.
L-Ornithine Promotes Parasite Growth and Restores Cellular
Infection in the Presence of LOHA. Results from Fig. 6
were made to further assess cellular infection in the absence
of functional NOS II and investigate the role of l-ornithine
in parasite growth. We have compared macrophages from
the resistant strain C57BL/6 NOS II–deficient mice with
their correspondent wild-type littermates (Fig. 6 A), and
those with the ones from susceptible BALB/c mice (Fig. 6
B). In activated BMMf, only cells with functional NOS II
are able to greatly reduce the number of amastigotes. In the
Figure 5. Effect of SOD on the inhibition of parasite infection by
LOHA. BALB/c macrophages were infected with L. infantum promasti-
gotes in the presence of increasing amounts of SOD alone (white bars) or
together with 100 mM LOHA (black bars). After 48 h, the number of in-
tracellular amastigotes in 100 cells (bars) and the percentage of infected
cells (numbers) were counted.
Figure 6. l-ornithine reverses the inhibitory ef-
fect of exogenous and endogenous LOHA. L. in-
fantum–infected BMMf from NOS II knockout
and C57BlL6 mice (A) or BALB/c mice (B), were
untreated or treated with LOHA or IFN-g plus
LPS in the absence or presence 250 mM l-ornithine
for 48 h. The results represent the number of
amastigotes in 100 cells and the percentage of infec-
tion (numbers). *P , 0.05 by Student’s paired t test.782 Inhibition of Leishmania Infection by Nv-Hydroxy-l-Arginine
presence of LOHA, the number of intracellular amastigotes
was inhibited by z75% in all infected cells. Moreover, ex-
ogenously added l-ornithine was able to significantly in-
crease the number of intracellular parasites in macrophages
from the three strains, and almost restore infection levels in
the presence of LOHA (75%) and IFN-g plus LPS (68%)
treated cells. These findings strongly suggest that the inhi-
bition of arginase from parasites is responsible for the effec-
tor mechanisms of exogenous LOHA. Furthermore, in
fully activated cells, its production via NOS II could also
have a role in the killing of Leishmania due to the reversion
observed in the presence of l-ornithine.
Our results are in agreement with the recently reported
affinity levels of l-arginine and LOHA to NOS II and argi-
nase I (23). NOS II has higher affinity for l-arginine than
for LOHA. In contrast, arginase I has much higher affinity
for its inhibitor, LOHA, than for its substrate. Thus, despite
the l-arginine concentrations present in cultures (1 mM for
RPMI), LOHA can inhibit arginase from parasites and also
the macrophage-induced isoform I. The result of inhibiting
arginase from Leishmania could explain the antiparasitic ef-
fect observed in control infected cells. Whereas, by inhibit-
ing macrophage-induced arginase I, LOHA could prevent
the growth achieved in the presence of IL-4.
Therefore, the results point to a dependence of the para-
sitic growth on an efficient macrophage-arginase I induc-
tion; this isoform, induced in the context of a Th2-type of
immune response, could optimally support the growth of
Leishmania.
As reported before, LOHA can also be metabolized by
oxidases other than NOS (12), or react with other radicals,
such as H2O2 (27), yielding alternative products. For this
reason, we do not discard the possibility that part of the ef-
fector mechanisms of LOHA could also be produced by
radical generation, including NO gas not detectable by the
Griess reaction. The toxic potential of NO, when exoge-
nously applied in the form of NO donors, was efficient in
killing Leishmania parasites in vitro (16, 28) and useful for
the treatment of cutaneous leishmaniasis (29).
Polyamine synthesis is essential for normal growth and
differentiation in Leishmania species (30). One of the main
research interests in molecular parasitology of this protozoa
is focused on ornithine decarboxylase gene expression and
activity. Moreover, a-difluoromethylornithine (DFMO),
an inhibitor of the enzyme, is being used against parasite
spreading, and pentamidine, an inhibitor of arginine and
polyamine transport (31), is actually the main substance for
the treatment of antimony-resistant human leishmaniasis
(32). This suggests that parasites with a functional arginase
are sensitive to ornithine depletion. Therefore, arginase-
specific inhibitors could be potential new substances of
pharmacological interest for the treatment of leishmaniasis.
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